News
- EPIC Biotech 2012... more
- BioTrinity 2012 conference ... more
- MEDILINK Awards 2012... more
- BIA Research and Development Conference... more
- 22nd ECCMID conference 2012... more
- Superbugs and Superdrugs 2012... more
- KWS BioTest has won a Biomedical iNet award!... more
- 51st ICAAC conference 2011... more
- KWS BioTest appoints first Non-Executive Director ... more
- KWS BioTest now on Twitter!... more
- Genesis 2011 conference... more
- 21st ECCMID/ 27th ICC conference 2011... more
Shaping Tomorrow's Solutions
Providing Preclinical (CRO) Contract Research for Efficacy Testing and Lead Compound Development
Email: info@kwsbiotest.co.uk
Welcome to KWS Bio Test
KWS BioTest is a leading edge preclinical contract research organisation (CRO), which works closely with clients to develop lead compounds as novel treatments for human disease.
We provide efficacy models within the core areas of:
We work with clients to understand the unique attributes of each individual programme, to design appropriate research and development protocols and to develop a truly bespoke and individual service. In doing so, we draw from our extensive expertise and range of technical skills, and are continually developing and validating new services to meet the demands of the modern pharmaceutical industry.
KWS BioTest is the winner of the South West Biomedical iNet Innovation Award for Growth!
KWS Bio Test – Providing preclinical (CRO) contract research for efficacy testing and lead compound development